| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $622K | -84.1% |
| Cost of Revenue | $222K | -77.7% |
| Gross Profit | $400K | -86.3% |
| R&D Expense | $19.1M | -8.8% |
| SG&A Expense | $9.1M | -43.9% |
| Operating Income | -$50.2M | -25.2% |
| Pre-tax Income | -$48.5M | -29.1% |
| Income Tax | -$1.6M | -2916.9% |
| Net Income | -$46.9M | -24.6% |
| EPS (Basic) | -$35.25 | -2742.7% |
| EPS (Diluted) | -$35.25 | -2742.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $11.9M | +304.7% |
| Short-term Investments | $26.8M | +0.0% |
| Accounts Receivable | $190K | +43.6% |
| Inventory | $992K | -7.5% |
| Current Assets | $13.7M | -57.6% |
| Total Assets | $24.7M | -61.3% |
| Current Liabilities | $3.5M | -51.6% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$29.1M | +0.1% |
| Capital Expenditures | $700K | -6.5% |
| Investing Cash Flow | $26.3M | +53.9% |
| Financing Cash Flow | $11.8M | — |
| Free Cash Flow | -$29.8M | +0.2% |
| $4.1M |
| -57.5% |
| Stockholders' Equity | $20.6M | -62.0% |